Streptamer versus tetramer-based selection of functional cytomegalovirus-specific T cells

Streptamer versus tetramer-based selection of functional cytomegalovirus-specific T cells

Cytomegalovirus (CMV) disease constitutes a serious complication after stem cell transplantation and has been treated by adoptive transfer of donor-derived CMV-specific CD8+ T cells. CMV-specific CD8+ T cells were selected by multimers, and the technologies may alter the function of these T cells. T...

Full description

Bibliographic Details
Main Authors:	Xin-Chao Wang, Hua Pang, Xun Xu, Anita Schmitt, Mathias Freund, Michael Schmitt, Bao-An Chen
Format:	Article
Language:	English
Published:	Elsevier 2013-06-01
Series:	Journal of the Formosan Medical Association
Subjects:	adoptive immunotherapy cytomegalovirus cytomegalovirus-specific T cells stem cell transplantation streptamers tetramer
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664612001866

Similar Items

Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection
by: Christopher P. Ouellette
Published: (2022-10-01)

Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation
by: Matthias J. Reddehase
Published: (2016-08-01)

Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children’s patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study
by: Yongsheng Ruan, et al.
Published: (2022-10-01)

Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme
by: Andrea eSchuessler, et al.
Published: (2014-10-01)

Cytomegalovirus infection in transplant recipients
by: Luiz Sergio Azevedo, et al.
Published: (2015-07-01)

The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme
by: Amin Daei Sorkhabi, et al.
Published: (2022-04-01)

Cytomegalovirus-Specific T Cells in Pediatric Liver Transplant Recipients
by: Songpon Getsuwan, et al.
Published: (2023-11-01)

Cytomegalovirus Infections in Children with Primary and Secondary Immune Deficiencies
by: Caroline M. Bateman, et al.
Published: (2021-10-01)

Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation
by: Thomas Poiret, et al.
Published: (2018-04-01)

Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation
by: Ian Pang, et al.
Published: (2022-01-01)

Genotyping clinical cytomegalovirus isolates in solid-organs-transplant recipients
by: O. E. Vankova, et al.
Published: (2022-01-01)

Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection
by: Evi B. Struble, et al.
Published: (2021-08-01)

Combining Adoptive Cell Therapy with Cytomegalovirus-Based Vaccine Is Protective against Solid Skin Tumors
by: Jeremy M. Grenier, et al.
Published: (2018-01-01)

Memory CD8 T Cells Protect against Cytomegalovirus Disease by Formation of Nodular Inflammatory Foci Preventing Intra-Tissue Virus Spread
by: Rafaela Holtappels, et al.
Published: (2022-05-01)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
by: Samantha Barnes, et al.
Published: (2020-11-01)

Peptide Vaccination against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients
by: Claudia Sommerer, et al.
Published: (2021-02-01)

Bilateral cytomegalovirus retinitis comorbid with diabetic macular edema
by: Yu-Jang Chao, et al.
Published: (2019-01-01)

Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
by: Dominika Deborska-Materkowska, et al.
Published: (2018-04-01)

Lymphocyte subpopulations during cytomegalovirus disease in renal transplant recipients
by: S.M. Castro, et al.
Published: (2003-06-01)

Cytomegalovirus Infection in Renal Recipients in Al_Zahra Hospital of Isfahan
by: Farzin Khorvash
Published: (2007-06-01)

PREVALENCE OF CYTOMEGALOVIRUS IN CHILDREN WHO RECEIVE BONE MARROW TRANSPLANTATION BY MEANS OF REAL-TIME POLYMERASE CHAIN REACTION
by: López-Montanero Edith Elizabeth, et al.
Published: (2015-01-01)

Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
by: Ümit Özçelik, et al.
Published: (2020-01-01)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
by: Amirhassan Rabbani, et al.
Published: (2022-09-01)

Cytomegalovirus lymphadenitis mimicking a relapsed diffuse large B‐cell lymphoma
by: Matthieu Delaye, et al.
Published: (2022-12-01)

Cytomegalovirus infection in gastrointestinal tract: A case series of three patients and review of literature
by: Piyush Ranjan, et al.
Published: (2015-07-01)

Cytomegalovirus Infection among Kidney Transplant Recipients One Year after Transplantation
by: Elham Shaeerbaf, et al.
Published: (2018-06-01)

Incidence and risk factors for cytomegalovirus in kidney transplant patients in Babol, northern Iran
by: Mostafa Javanian, et al.
Published: (2017-01-01)

The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
by: Masoud Mardani, et al.
Published: (2020-12-01)

Correlation between viral load of cytomegalovirus and tacrolimus and sirolimus levels in transplanted pediatric patients
by: Herlinda Reyes-Pérez, et al.
Published: (2016-01-01)

Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications
by: Claudio Annaloro, et al.
Published: (2021-01-01)

Cytomegalovirus infection in solid malignancies
by: Amit Kumar Agrawal, et al.
Published: (2020-01-01)

Foscarnet-Resistant Cytomegalovirus Esophagitis with Stricturing
by: Vinaya Gaduputi, et al.
Published: (2013-01-01)

QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country
by: Kritsada Pongsakornkullachart, et al.
Published: (2022-05-01)

Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review
by: Alice Tung Wan Song, et al.

Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients
by: Katharina Göhring, et al.
Published: (2015-01-01)

Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant Patients
by: Po-Jung Hsu, et al.
Published: (2021-10-01)

Laboratory diagnostic testing for cytomegalovirus infection in solid organ transplant patients
by: Hyeyoung Lee, et al.
Published: (2022-03-01)

Rat cytomegalovirus genome scaffold and A033 gene as infection marker in rats
by: Camalxaman, Siti Nazrina
Published: (2013)

Cytomegalovirus DNAemia in kidney transplant recipients after cessation of standard antiviral prophylaxis; estimated rate on Thai cases and implication on efficacy of prophylaxis
by: Won Sriwijitalai, et al.
Published: (2019-05-01)

Monitoring of cytomegalovirus infection after allogeneic stem cell transplantation
by: Kuljić-Kapulica Nada, et al.
Published: (2010-01-01)